Antioxidant Effect of Polyoxidonium and Metaprot during Bronchopulmonary Inflammation in Rats

I V Zarubina1, P D Shabanov2

  • 1Department of Pharmacology, Military Medical Academy, Ministry of Defense of the Russian Federation, St. Petersburg, Russia.

Insights

Polyoxidonium and metaprot show antioxidant effects in lung inflammation. Combined application yields a stronger antioxidant impact than either substance alone, offering potential therapeutic benefits.

Area of Science:

  • Pharmacology
  • Toxicology
  • Biochemistry

Background:

  • Acute bronchopulmonary inflammation is a significant health concern.
  • Antioxidants play a crucial role in mitigating inflammatory processes.
  • Understanding the synergistic effects of therapeutic agents is vital for effective treatment strategies.

Purpose of the Study:

  • To investigate the antioxidant effects of polyoxidonium and metaprot, individually and in combination.
  • To evaluate the impact of these agents on acute bronchopulmonary inflammation in a rat model.
  • To assess the dose-dependent effects on alveolar macrophage biochemiluminescence.

Main Methods:

  • Utilized a rat model of acute bronchopulmonary inflammation.
  • Administered polyoxidonium and metaprot individually and in combination.
  • Measured antioxidant potency and spontaneous biochemiluminescence in alveolar macrophages.

Main Results:

  • Metaprot demonstrated greater individual antioxidant potency than polyoxidonium.
  • The combined application of polyoxidonium and metaprot resulted in a more potent antioxidant effect.
  • Both agents modulated spontaneous biochemiluminescence in alveolar macrophages in a concentration-dependent manner: low concentrations increased, while high concentrations suppressed it.

Conclusions:

  • Polyoxidonium and metaprot exhibit significant antioxidant properties in the context of acute bronchopulmonary inflammation.
  • Combined administration of these agents offers enhanced therapeutic potential compared to monotherapy.
  • The concentration-dependent modulation of macrophage activity suggests a complex regulatory role.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.0K
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
2.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
3.4K